Tenet Healthcare Stock
Tenet Healthcare Stock
A loss of -2.310% shows a downward development for Tenet Healthcare.
The stock is an absolute favorite of our community with 32 Buy predictions and no Sell predictions.
At the moment Tenet Healthcare has reached the predicted target price of 129 €, with a current price of 129.0 €.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | -2.310% | 4.032% | 10.256% | 79.167% | 86.957% | 131.931% | 618.423% |
| Amn Healthcare Svs | 1.650% | 0.000% | -12.920% | -50.051% | -26.567% | -36.923% | 7.096% |
| Chemed Corp. | 0.810% | 0.000% | -5.143% | - | - | - | - |
| Select Medical Holdings | 1.950% | -0.633% | 0.641% | - | - | - | - |
Comments
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at JPMorgan Chase & Co. from $107.00 to $140.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $126.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat